Dow Up0.76% Nasdaq Up0.69%

Sorrento Therapeutics, Inc. (SRNE)

-NasdaqCM
4.05 Up 0.03(0.75%) Oct 24, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 775   976   101   83  
Cost of Revenue510  563  4   -  
Gross Profit 265   413   96   83  
Operating Expenses
Research Development5,309  6,107  3,395  2,082  
Selling General and Administrative2,361  3,385  2,565  995  
Non Recurring -  209  4,776   -  
Others586  586  491  313  
Total Operating Expenses -  10,287  11,226   -  
Operating Income or Loss (7,991) (9,874) (11,130) (3,307)
Income from Continuing Operations
Total Other Income/Expenses Net5  4  4  2  
Earnings Before Interest And Taxes(7,986)(9,870)(11,126)(3,305)
Interest Expense468  223  170  51  
Income Before Tax(8,454)(10,093)(11,296)(3,356)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(8,454)(10,093)(11,296)(3,356)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (8,454) (10,093) (11,296) (3,356)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (8,454) (10,093) (11,296) (3,356)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.